PDF factsheet
      Z

Drug eluting stent in coronary artery disease for in stent restenosis, clinical trials results

paclitaxel eluting balloon versus brachytherapy
TAXUS V ISR, 2006
NCT00287573
TAXUS Express2
versus
angioplasty followed by vascular brachytherapy with a beta source
patients with restenotic lesions after prior stent implantation in native coronary arteriesopen
North America
sirolimus eluting stent versus brachytherapy
SISR, 2007
NCT00231257
Sirolimus-eluting stents
versus
brachytherapy
restenosis within a bare metal stentopen
Follow-up duration: 12 months
US and Canadian
sirolimus eluting stent versus paclitaxel eluting stent
ISAR-DESIRE (SES vs PES), 2005
Cypher
versus
Taxus
In-stent restenosis. AP and/or positive test, previously stented, no AMIopen
Follow-up duration: 1y
germany
ISAR-DESIRE-2, 2010
NCT00598715
sirolimus-eluting stent
versus
paclitaxel-eluting stent
coronary restenosis in sirolimus-eluting stentsopen
Follow-up duration: 1y
Germany
sirolimus eluting stent versus PTCA
CRISTAL, 0
NCT00323895
sirolimus-eluting stent
versus
balloon re-percutaneous transluminal coronary angioplasty
Intra-Des Restenosis
RIBS-II, 2008
sirolimus-eluting stents
versus
Balloon angioplasty
patients with bare metal in-stent restenosis open
Follow-up duration: >1 year
Spanish

  Options


in first

in second

  Filter